Company intelligence / Profile preview

Advanced Pharmaceutical Industries

Jeddah, Makkah, Saudi Arabiaadv-pharma.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Advanced Pharmaceutical Industries manufactures a portfolio of 32+ pharmaceutical products in various dosage forms. The company focuses on providing niche products with long life cycles that are highly demanded in the MENA region. It operates under EU-GMP standards and aims to fill gaps in the regional market by producing medicines not otherwise available locally. No specific clinical trial results are disclosed.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: Small molecules (oral and injectable forms)sterile liquid dosage forms for injectables
Industry: Biotech

Drug pipeline

2 assets

glatiramer acetate

Commercial

Indications: Multiple sclerosis

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Advanced Pharmaceutical Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Pharmaceutical Industries.

Explore the full profile